请输入您要查询的百科知识:

 

词条 Systematic evolution of ligands by exponential enrichment
释义

  1. Procedure

      Generating single stranded oligonucleotide library    Target incubation    Binding sequence elution and amplification   Obtaining ssDNA   Negative or counter selection    Tracking selection progression    Caveats and considerations  

  2. Chemically modified nucleotides

  3. Prior targets

  4. See also

  5. References

  6. Further reading

  7. External links

Systematic evolution of ligands by exponential enrichment (SELEX), also referred to as in vitro selection or in vitro evolution, is a combinatorial chemistry technique in molecular biology for producing oligonucleotides of either single-stranded DNA or RNA that specifically bind to a target ligand or ligands, which are commonly referred to as aptamers.[1][2][3]

Although SELEX has emerged as the most commonly used name for the procedure, some researchers have referred to it as SAAB (selected and amplified binding site) and CASTing (cyclic amplification and selection of targets)[4][5] SELEX was first introduced in 1990. In 2015 a special issue was published in the Journal of Molecular Evolution in the honor of quarter century of the SELEX discovery [6].

The process begins with the synthesis of a very large oligonucleotide library consisting of randomly generated sequences of fixed length flanked by constant 5' and 3' ends that serve as primers.[2] For a randomly generated region of length n, the number of possible sequences in the library is 4n (n positions with four possibilities (A,T,C,G) at each position). The sequences in the library are exposed to the target ligand - which may be a protein or a small organic compound - and those that do not bind the target are removed, usually by affinity chromatography or target capture on paramagnetic beads.[7] The bound sequences are eluted and amplified by PCR[2][3] to prepare for subsequent rounds of selection in which the stringency of the elution conditions can be increased to identify the tightest-binding sequences.[2] A caution to consider in this method is that the selection of extremely high, sub-nanomolar binding affinity entities may not in fact improve specificity for the target molecule.[8] Off-target binding to related molecules could have significant clinical effects.

SELEX has been used to develop a number of aptamers that bind targets interesting for both clinical and research purposes.[9] Also towards these ends, a number of nucleotides with chemically modified sugars and bases have been incorporated into SELEX reactions.[9][10] These modified nucleotides allow for the selection of aptamers with novel binding properties and potentially improved stability.[9][10]

Procedure

Generating single stranded oligonucleotide library

The first step of SELEX involves the synthesis of fully or partially randomized oligonucleotide sequences of some length flanked by defined regions which allow PCR amplification of those randomized regions and, in the case of RNA SELEX, in vitro transcription of the randomized sequence.[2][3][11] While Ellington and Szostak demonstrated that chemical synthesis is capable of generating ~1015 unique sequences for oligonucleotide libraries in their 1990 paper on in vitro selection,[3] they found that amplification of these synthesized oligonucleotides led to significant loss of pool diversity due to PCR bias and defects in synthesized fragments.[3] The oligonucleotide pool is amplified and a sufficient amount of the initial library is added to the reaction so that there are numerous copies of each individual sequence to minimize the loss of potential binding sequences due to stochastic events.[3] Before the library is introduced to target for incubation and selective retention, the sequence library must be converted to single stranded oligonucleotides to achieve structural conformations with target binding properties.[2][3]

Target incubation

Immediately prior to target introduction, the single stranded oligonucleotide library is often heated and cooled slowly to renature oligonucleotides into thermodynamically stable secondary and tertiary structures.[3][7] Once prepared, the randomized library is incubated with immobilized target to allow oligonucleotide-target binding. There are several considerations for this target incubation step, including the target immobilization method and strategies for subsequent unbound oligonucleotide separation, incubation time and temperature, incubation buffer conditions, and target versus oligonucleotide concentrations. Examples of target immobilization methods include affinity chromatography columns,[3] nitrocellulose binding assay filters,[2] and paramagnetic beads.[7] Recently, SELEX reactions have been developed where the target is whole cells, which are expanded near complete confluence and incubated with the oligonucleotide library on culture plates.[12] Incubation buffer conditions are altered based on the intended target and desired function of the selected aptamer. For example, in the case of negatively charged small molecules and proteins, high salt buffers are used for charge screening to allow nucleotides to approach the target and increase the chance of a specific binding event.[3] Alternatively, if the desired aptamer function is in vivo protein or whole cell binding for potential therapeutic or diagnostic application, incubation buffer conditions similar to in vivo plasma salt concentrations and homeostatic temperatures are more likely to generate aptamers that can bind in vivo. Another consideration in incubation buffer conditions is non-specific competitors. If there is a high likelihood of non-specific oligonucleotide retention in the reaction conditions, non specific competitors, which are small molecules or polymers other than the SELEX library that have similar physical properties to the library oligonucleotides, can be used to occupy these non-specific binding sites.[12] Varying the relative concentration of target and oligonucleotides can also affect properties of the selected aptamers. If a good binding affinity for the selected aptamer is not a concern, then an excess of target can be used to increase the probability that at least some sequences will bind during incubation and be retained. However, this provides no selective pressure for high binding affinity, which requires the oligonucleotide library to be in excess so that there is competition between unique sequences for available specific binding sites.[2]

Binding sequence elution and amplification

Once the oligonucleotide library has been incubated with target for sufficient time, unbound oligonucleotides are washed away from immobilized target, often using the incubation buffer so that specifically bound oligonucleotides are retained.[3] With unbound sequences washed away, the specifically bound sequences are then eluted by creating denaturing conditions that promote oligonucleotide unfolding or loss of binding conformation including flowing in deionized water,[3] using denaturing solutions containing urea and EDTA,[12][13] or by applying high heat and physical force.[7] Upon elution of bound sequences, the retained oligonucleotides are reverse-transcribed to DNA in the case of RNA or modified base selections,[2][3][12] or simply collected for amplification in the case of DNA SELEX.[14] These DNA templates from eluted sequences are then amplified via PCR and converted to single stranded DNA, RNA, or modified base oligonucleotides, which are used as the initial input for the next round of selection.[2][3]

Obtaining ssDNA

One of the most critical steps in the SELEX procedure is obtaining single stranded DNA (ssDNA) after the PCR amplification step. This will serve as input for the next cycle so it is of vital importance that all the DNA is single stranded and as little as possible is lost. Because of the relative simplicity, one of the most used methods is using biotinylated reverse primers in the amplification step, after which the complementary strands can be bound to a resin followed by elution of the other strand with lye. Another method is asymmetric PCR, where the amplification step is performed with an excess of forward primer and very little reverse primer, which leads to the production of more of the desired strand. A drawback of this method is that the product should be purified from double stranded DNA (dsDNA) and other left-over material from the PCR reaction. Enzymatic degradation of the unwanted strand can be performed by tagging this strand using a phosphate-probed primer, as it is recognized by enzymes such as Lambda exonuclease. These enzymes then selectively degrade the phosphate tagged strand leaving the complementary strand intact. All of these methods recover approximately 50 to 70% of the DNA. For a detailed comparison refer to the article by Svobodová et al. where these, and other, methods are experimentally compared.[15] In classical SELEX, the process of randomized single stranded library generation, target incubation, and binding sequence elution and amplification described above are repeated until the vast majority of the retained pool consists of target binding sequences,[2][3] though there are modifications and additions to the procedure that are often used, which are discussed below.

Negative or counter selection

In order to increase the specificity of aptamers selected by a given SELEX procedure, a negative selection, or counter selection, step can be added prior to or immediately following target incubation. To eliminate sequences with affinity for target immobilization matrix components from the pool, negative selection can be used where the library is incubated with target immobilization matrix components and unbound sequences are retained.[13][16][14] Negative selection can also be used to eliminate sequences that bind target-like molecules or cells by incubating the oligonucleotide library with small molecule target analogs, undesired cell types, or non-target proteins and retaining the unbound sequences.[12][14][17]

Tracking selection progression

To track the progress of a SELEX reaction, the number of target bound molecules, which is equivalent to the number of oligonucleotides eluted, can be compared to the estimated total input of oligonucleotides following elution at each round.[3][18] The number of eluted oligonucleotides can be estimated through elution concentration estimations via 260 nm wavelength absorbance[18] or fluorescent labeling of oligonucleotides.[7] As the SELEX reaction approaches completion, the fraction of the oligonucleotide library that binds target approaches 100%, such that the number of eluted molecules approaches the total oligonucleotide input estimate, but may converge at a lower number.[3]

Caveats and considerations

Some SELEX reactions can generate probes that are dependent on primer binding regions for secondary structure formation.[7] There are aptamer applications for which a short sequence, and thus primer truncation, is desirable.[19] An advancement on the original method allows an RNA library to omit the constant primer regions, which can be difficult to remove after the selection process because they stabilize secondary structures that are unstable when formed by the random region alone.[20]

Chemically modified nucleotides

Recently, SELEX has expanded to include the use of chemically modified nucleotides. These chemically modified oligonucleotides offer many potential advantages for selected aptamers including greater stability and nuclease resistance, enhanced binding for select targets, expanded physical properties - like increased hydrophobicity, and more diverse structural conformations.[9][10][21]

The genetic alphabet, and thus possible aptamers, is also expanded using unnatural base pairs[22][23] the use of these unnatural base pairs was applied to SELEX and high affinity DNA aptamers were generated.[24]

Prior targets

The technique has been used to evolve aptamers of extremely high binding affinity to a variety of target ligands, including small molecules such as ATP[25] and adenosine[11][26] and proteins such as prions[27] and vascular endothelial growth factor (VEGF).[28] Moreover, SELEX has been used to select high-affinity aptamers for complex targets such as tumor cells.[29] Clinical uses of the technique are suggested by aptamers that bind tumor markers,[30] GFP-related fluorophores,[31] and a VEGF-binding aptamer trade-named Macugen has been approved by the FDA for treatment of macular degeneration.[28][32] Additionally, SELEX has been utilized to obtain highly specific catalytic DNA or DNAzymes. Several metal-specific DNAzymes have been reported including the GR-5 DNAzyme (lead-specific),[33] the CA1-3 DNAzymes (copper-specific),[34] the 39E DNAzyme (uranyl-specific) [35] and the NaA43 DNAzyme (sodium-specific).[36]

These developed aptamers have seen diverse application in therapies for macular degeneration[32] and various research applications including biosensors,[19] fluorescent labeling of proteins[37] and cells,[38] and selective enzyme inhibition.[39]

See also

  • Aptamer
  • Deoxyribozyme
  • Anti-thrombin aptamers
  • Bacterial one-hybrid system

References

1. ^{{cite journal | vauthors = Hak-Hagir A | title = [The Hak-Hagir skin conduit] | journal = Zeitschrift Fur Urologie und Nephrologie | volume = 71 | issue = 9 | pages = 639–42 | date = September 1978 | pmc = 362762 | doi = 10.1128/mcb.9.7.2944 | pmid = 2674675 }}
2. ^10 {{cite journal | vauthors = Tuerk C, Gold L | title = Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase | journal = Science | volume = 249 | issue = 4968 | pages = 505–10 | date = August 1990 | pmid = 2200121 | doi = 10.1126/science.2200121 | bibcode = 1990Sci...249..505T }}
3. ^10 11 12 13 14 15 16 {{cite journal | vauthors = Ellington AD, Szostak JW | title = In vitro selection of RNA molecules that bind specific ligands | journal = Nature | volume = 346 | issue = 6287 | pages = 818–22 | date = August 1990 | pmid = 1697402 | doi = 10.1038/346818a0 | bibcode = 1990Natur.346..818E }}
4. ^{{cite journal | vauthors = Blackwell TK, Weintraub H | title = Differences and similarities in DNA-binding preferences of MyoD and E2A protein complexes revealed by binding site selection | journal = Science | volume = 250 | issue = 4984 | pages = 1104–10 | date = November 1990 | pmid = 2174572 | doi = 10.1126/science.2174572 | bibcode = 1990Sci...250.1104B }}
5. ^{{cite journal | vauthors = Wright WE, Binder M, Funk W | title = Cyclic amplification and selection of targets (CASTing) for the myogenin consensus binding site | journal = Molecular and Cellular Biology | volume = 11 | issue = 8 | pages = 4104–10 | date = August 1991 | pmid = 1649388 | pmc = 361222 | doi = 10.1128/mcb.11.8.4104 }}
6. ^{{cite journal |last1=Gold |first1=Larry |title=SELEX: How It Happened and Where It will Go |journal=Journal of Molecular Evolution |date=October 20, 2015 |volume=81 |issue=5–6 |pages=140–3 |doi=10.1007/s00239-015-9705-9 |pmid=26480964 |pmc=4661202 }}
7. ^{{cite journal | vauthors = Stoltenburg R, Schubert T, Strehlitz B | title = In vitro Selection and Interaction Studies of a DNA Aptamer Targeting Protein A | journal = PLOS One | volume = 10 | issue = 7 | pages = e0134403 | date = 2015-07-29 | pmid = 26221730 | pmc = 4519192 | doi = 10.1371/journal.pone.0134403 }}
8. ^{{cite journal | vauthors = Carothers JM, Oestreich SC, Szostak JW | title = Aptamers selected for higher-affinity binding are not more specific for the target ligand | journal = Journal of the American Chemical Society | volume = 128 | issue = 24 | pages = 7929–37 | date = June 2006 | pmid = 16771507 | pmc = 4287982 | doi = 10.1021/ja060952q }}
9. ^{{cite journal | vauthors = Wu YX, Kwon YJ | title = Aptamers: The "evolution" of SELEX | journal = Methods | volume = 106 | pages = 21–8 | date = August 2016 | pmid = 27109056 | doi = 10.1016/j.ymeth.2016.04.020 }}
10. ^{{cite journal | vauthors = Keefe AD, Cload ST | title = SELEX with modified nucleotides | journal = Current Opinion in Chemical Biology | volume = 12 | issue = 4 | pages = 448–56 | date = August 2008 | pmid = 18644461 | doi = 10.1016/j.cbpa.2008.06.028 }}
11. ^{{cite journal | vauthors = Huizenga DE, Szostak JW | title = A DNA aptamer that binds adenosine and ATP | journal = Biochemistry | volume = 34 | issue = 2 | pages = 656–65 | date = January 1995 | pmid = 7819261 | doi = 10.1021/bi00002a033 }}
12. ^{{cite journal | vauthors = Iwagawa T, Ohuchi SP, Watanabe S, Nakamura Y | title = Selection of RNA aptamers against mouse embryonic stem cells | journal = Biochimie | volume = 94 | issue = 1 | pages = 250–7 | date = January 2012 | pmid = 22085640 | doi = 10.1016/j.biochi.2011.10.017 }}
13. ^{{cite journal | vauthors = Vater A, Jarosch F, Buchner K, Klussmann S | title = Short bioactive Spiegelmers to migraine-associated calcitonin gene-related peptide rapidly identified by a novel approach: tailored-SELEX | journal = Nucleic Acids Research | volume = 31 | issue = 21 | pages = 130e–130 | date = November 2003 | pmid = 14576330 | pmc = 275487 | doi = 10.1093/nar/gng130 }}
14. ^{{cite journal | vauthors = Blank M, Weinschenk T, Priemer M, Schluesener H | title = Systematic evolution of a DNA aptamer binding to rat brain tumor microvessels. selective targeting of endothelial regulatory protein pigpen | journal = The Journal of Biological Chemistry | volume = 276 | issue = 19 | pages = 16464–8 | date = May 2001 | pmid = 11279054 | doi = 10.1074/jbc.M100347200 }}
15. ^{{cite journal | vauthors = Svobodová M, Pinto A, Nadal P, O' Sullivan CK | title = Comparison of different methods for generation of single-stranded DNA for SELEX processes | journal = Analytical and Bioanalytical Chemistry | volume = 404 | issue = 3 | pages = 835–42 | date = August 2012 | pmid = 22733247 | doi = 10.1007/s00216-012-6183-4 }}
16. ^{{cite journal | vauthors = Stoltenburg R, Reinemann C, Strehlitz B | title = SELEX--a (r)evolutionary method to generate high-affinity nucleic acid ligands | journal = Biomolecular Engineering | volume = 24 | issue = 4 | pages = 381–403 | date = October 2007 | pmid = 17627883 | doi = 10.1016/j.bioeng.2007.06.001 }}
17. ^{{cite journal | vauthors = Haller AA, Sarnow P | title = In vitro selection of a 7-methyl-guanosine binding RNA that inhibits translation of capped mRNA molecules | journal = Proceedings of the National Academy of Sciences of the United States of America | volume = 94 | issue = 16 | pages = 8521–6 | date = August 1997 | pmid = 9238009 | pmc = 22984 | doi = 10.1073/pnas.94.16.8521 }}
18. ^{{cite journal | vauthors = Sefah K, Shangguan D, Xiong X, O'Donoghue MB, Tan W | title = Development of DNA aptamers using Cell-SELEX | language = En | journal = Nature Protocols | volume = 5 | issue = 6 | pages = 1169–85 | date = June 2010 | pmid = 20539292 | doi = 10.1038/nprot.2010.66 }}
19. ^{{cite journal | vauthors = Lubin AA, Hunt BV, White RJ, Plaxco KW | title = Effects of probe length, probe geometry, and redox-tag placement on the performance of the electrochemical E-DNA sensor | language = EN | journal = Analytical Chemistry | volume = 81 | issue = 6 | pages = 2150–8 | date = March 2009 | pmid = 19215066 | doi = 10.1021/ac802317k }}
20. ^{{cite journal | vauthors = Jarosch F, Buchner K, Klussmann S | title = In vitro selection using a dual RNA library that allows primerless selection | journal = Nucleic Acids Research | volume = 34 | issue = 12 | pages = e86 | date = July 2006 | pmid = 16855281 | pmc = 1524915 | doi = 10.1093/nar/gkl463 }}
21. ^{{cite journal | vauthors = Pinheiro VB, Taylor AI, Cozens C, Abramov M, Renders M, Zhang S, Chaput JC, Wengel J, Peak-Chew SY, McLaughlin SH, Herdewijn P, Holliger P | title = Synthetic genetic polymers capable of heredity and evolution | journal = Science | volume = 336 | issue = 6079 | pages = 341–4 | date = April 2012 | pmid = 22517858 | pmc = 3362463 | doi = 10.1126/science.1217622 }}
22. ^{{cite journal | vauthors = Kimoto M, Kawai R, Mitsui T, Yokoyama S, Hirao I | title = An unnatural base pair system for efficient PCR amplification and functionalization of DNA molecules | journal = Nucleic Acids Research | volume = 37 | issue = 2 | pages = e14 | date = February 2009 | pmid = 19073696 | pmc = 2632903 | doi = 10.1093/nar/gkn956 }}
23. ^{{cite journal | vauthors = Yamashige R, Kimoto M, Takezawa Y, Sato A, Mitsui T, Yokoyama S, Hirao I | title = Highly specific unnatural base pair systems as a third base pair for PCR amplification | journal = Nucleic Acids Research | volume = 40 | issue = 6 | pages = 2793–806 | date = March 2012 | pmid = 22121213 | pmc = 3315302 | doi = 10.1093/nar/gkr1068 }}
24. ^{{cite journal | vauthors = Kimoto M, Yamashige R, Matsunaga K, Yokoyama S, Hirao I | title = Generation of high-affinity DNA aptamers using an expanded genetic alphabet | journal = Nature Biotechnology | volume = 31 | issue = 5 | pages = 453–7 | date = May 2013 | pmid = 23563318 | doi = 10.1038/nbt.2556 }}
25. ^{{cite journal | vauthors = Dieckmann T, Suzuki E, Nakamura GK, Feigon J | title = Solution structure of an ATP-binding RNA aptamer reveals a novel fold | journal = RNA | volume = 2 | issue = 7 | pages = 628–40 | date = July 1996 | pmid = 8756406 | pmc = 1369402 }}
26. ^{{cite journal | vauthors = Burke DH, Gold L | title = RNA aptamers to the adenosine moiety of S-adenosyl methionine: structural inferences from variations on a theme and the reproducibility of SELEX | journal = Nucleic Acids Research | volume = 25 | issue = 10 | pages = 2020–4 | date = May 1997 | pmid = 9115371 | pmc = 146680 | doi = 10.1093/nar/25.10.2020 }}
27. ^{{cite journal | vauthors = Mercey R, Lantier I, Maurel MC, Grosclaude J, Lantier F, Marc D | title = Fast, reversible interaction of prion protein with RNA aptamers containing specific sequence patterns | journal = Archives of Virology | volume = 151 | issue = 11 | pages = 2197–214 | date = November 2006 | pmid = 16799875 | doi = 10.1007/s00705-006-0790-3 }}
28. ^{{cite journal | vauthors = Ulrich H, Trujillo CA, Nery AA, Alves JM, Majumder P, Resende RR, Martins AH | title = DNA and RNA aptamers: from tools for basic research towards therapeutic applications | journal = Combinatorial Chemistry & High Throughput Screening | volume = 9 | issue = 8 | pages = 619–32 | date = September 2006 | pmid = 17017882 | doi = 10.2174/138620706778249695 }}
29. ^{{cite journal | vauthors = Daniels DA, Chen H, Hicke BJ, Swiderek KM, Gold L | title = A tenascin-C aptamer identified by tumor cell SELEX: systematic evolution of ligands by exponential enrichment | journal = Proceedings of the National Academy of Sciences of the United States of America | volume = 100 | issue = 26 | pages = 15416–21 | date = December 2003 | pmid = 14676325 | pmc = 307582 | doi = 10.1073/pnas.2136683100 | bibcode = 2003PNAS..10015416D }}
30. ^{{cite journal | vauthors = Ferreira CS, Matthews CS, Missailidis S | title = DNA aptamers that bind to MUC1 tumour marker: design and characterization of MUC1-binding single-stranded DNA aptamers | journal = Tumour Biology | volume = 27 | issue = 6 | pages = 289–301 | year = 2006 | pmid = 17033199 | doi = 10.1159/000096085 }}
31. ^{{cite journal | vauthors = Paige JS, Wu KY, Jaffrey SR | title = RNA mimics of green fluorescent protein | journal = Science | volume = 333 | issue = 6042 | pages = 642–6 | date = July 2011 | pmid = 21798953 | pmc = 3314379 | doi = 10.1126/science.1207339 | bibcode = 2011Sci...333..642P }}
32. ^{{cite journal | vauthors = Vavvas D, D'Amico DJ | title = Pegaptanib (Macugen): treating neovascular age-related macular degeneration and current role in clinical practice | journal = Ophthalmology Clinics of North America | volume = 19 | issue = 3 | pages = 353–60 | date = September 2006 | pmid = 16935210 | doi = 10.1016/j.ohc.2006.05.008 | doi-broken-date = 2019-02-21 }}
33. ^{{cite journal | vauthors = Breaker RR, Joyce GF | title = A DNA enzyme that cleaves RNA | journal = Chemistry & Biology | volume = 1 | issue = 4 | pages = 223–9 | date = December 1994 | pmid = 9383394 | doi = 10.1016/1074-5521(94)90014-0 }}
34. ^{{cite journal | vauthors = Carmi N, Shultz LA, Breaker RR | title = In vitro selection of self-cleaving DNAs | journal = Chemistry & Biology | volume = 3 | issue = 12 | pages = 1039–46 | date = December 1996 | pmid = 9000012 | doi = 10.1016/s1074-5521(96)90170-2 }}
35. ^{{cite journal | vauthors = Liu J, Brown AK, Meng X, Cropek DM, Istok JD, Watson DB, Lu Y | title = A catalytic beacon sensor for uranium with parts-per-trillion sensitivity and millionfold selectivity | journal = Proceedings of the National Academy of Sciences of the United States of America | volume = 104 | issue = 7 | pages = 2056–61 | date = February 2007 | pmid = 17284609 | pmc = 1892917 | doi = 10.1073/pnas.0607875104 | bibcode = 2007PNAS..104.2056L }}
36. ^{{cite journal | vauthors = Torabi SF, Wu P, McGhee CE, Chen L, Hwang K, Zheng N, Cheng J, Lu Y | title = In vitro selection of a sodium-specific DNAzyme and its application in intracellular sensing | journal = Proceedings of the National Academy of Sciences of the United States of America | volume = 112 | issue = 19 | pages = 5903–8 | date = May 2015 | pmid = 25918425 | pmc = 4434688 | doi = 10.1073/pnas.1420361112 | bibcode = 2015PNAS..112.5903T }}
37. ^{{Cite journal | vauthors = Umrao S, Jain V, Chakraborty B, Roy R | title = Protein-induced fluorescence enhancement as aptamer sensing mechanism for thrombin detection. | journal = Sensors and Actuators B: Chemical | date = August 2018 | volume = 267 | pages = 294–301 | doi = 10.1016/j.snb.2018.04.039 }}
38. ^{{cite journal | vauthors = Terazono H, Anzai Y, Soloviev M, Yasuda K | title = Labelling of live cells using fluorescent aptamers: binding reversal with DNA nucleases | journal = Journal of Nanobiotechnology | volume = 8 | issue = 1 | pages = 8 | date = April 2010 | pmid = 20388214 | pmc = 2861636 | doi = 10.1186/1477-3155-8-8 }}
39. ^{{cite journal | vauthors = Mondragón E, Maher LJ | title = RNA aptamer inhibitors of a restriction endonuclease | journal = Nucleic Acids Research | volume = 43 | issue = 15 | pages = 7544–55 | date = September 2015 | pmid = 26184872 | pmc = 4551934 | doi = 10.1093/nar/gkv702 }}

Further reading

{{refbegin}}
  • {{cite journal | vauthors = Levine HA, Nilsen-Hamilton M | title = A mathematical analysis of SELEX | journal = Computational Biology and Chemistry | volume = 31 | issue = 1 | pages = 11–35 | date = February 2007 | pmid = 17218151 | pmc = 2374838 | doi = 10.1016/j.compbiolchem.2006.10.002 }}
  • {{cite journal | vauthors = Spill F, Weinstein ZB, Irani Shemirani A, Ho N, Desai D, Zaman MH | title = Controlling uncertainty in aptamer selection | journal = Proceedings of the National Academy of Sciences of the United States of America | volume = 113 | issue = 43 | pages = 12076–12081 | date = October 2016 | pmid = 27790993 | pmc = 5087011 | doi = 10.1073/pnas.1605086113 | arxiv = 1612.08995 | bibcode = 2016PNAS..11312076S }}
{{refend}}

External links

  • Aptamer Base

2 : Molecular biology|Evolution

随便看

 

开放百科全书收录14589846条英语、德语、日语等多语种百科知识,基本涵盖了大多数领域的百科知识,是一部内容自由、开放的电子版国际百科全书。

 

Copyright © 2023 OENC.NET All Rights Reserved
京ICP备2021023879号 更新时间:2024/9/21 22:40:57